Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04131062 · ClinicalTrials.gov registry record · NA
Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants
A NA study of Lynch Syndrome, sponsored by Geisinger Clinic.
- Completed
- Registry status
- NA
- Development phase
- 703
- Enrollment target
- 1
- Study location
NCT04131062: Completed NA study of Lynch Syndrome, sponsored by Geisinger Clinic.
NCT04131062 is a NA study of Lynch Syndrome that has completed, run by Geisinger Clinic. The registered enrollment target is 703 participants, below the 2,283-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (69% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04131062, a NA study of Lynch Syndrome, has completed, sponsored by Geisinger Clinic.
- COMPLETED
- Registry status
- NA
- Development phase
- 703 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this trial is to determine whether the Sage eConsent framework (presented using an electronic application) is non-inferior to traditional, paper-based, human-mediated consent-and therefore could be part of an acceptable population screening approach to identifying patients and others with actionable hereditary syndromes-and to increase basic knowledge about patients' informational needs about different aspects of genetic/omic screening. After receiving either 1) the traditional consenting approach, or 2) a consenting approach presented on an electronic tablet, the investigators will test for differences between these two arms in a variety of outcome measures including objective and perceived comprehension, time spent and informational needs, and enrollment decision, among others.
Primary Outcome
Objective comprehension quiz score measured using 10-item quiz (minimum = 0; maximum = 10; higher scores indicate greater comprehension)
Conditions Studied
Interventions
- BEHAVIORAL Electronic Consent (iPad)
Study Locations (1)
Pennsylvania
- Geisinger - Danville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 703 participants |
| Start Date | 2019-11-01 |
| Est. Completion | 2022-05-19 |
| Phase | NA |
What the finished NCT04131062 record still lists
NCT04131062 is an interventional study that assigns participants to a tested intervention. The registered 703 participants enrollment target is mid-sized for trials with a published cap, below the 2,283-participant average among 21 other Lynch Syndrome trials with a reported enrollment target (69% lower).
The record links to 1 condition, with Lynch Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Electronic Consent (iPad) is the first listed.
NCT04131062 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT04131062 about?
NCT04131062 is a clinical study titled "Trial to Compare eConsent With Standard Consent Among Prospective Biobank Participants". The goal of this trial is to determine whether the Sage eConsent framework (presented using an electronic application) is non-inferior to traditional, paper-based, human-mediated consent-and therefore could be part of an acceptable population screening approach to identifying patients and others wit...
What is the current status of trial NCT04131062?
This trial is currently completed. It is a NA study. The enrollment target is 703 participants. The study started on 2019-11-01. Estimated completion is 2022-05-19.
What conditions does trial NCT04131062 study?
This clinical trial studies the following conditions: Lynch Syndrome.
What interventions are being tested in trial NCT04131062?
The interventions under investigation include: Electronic Consent (iPad) (BEHAVIORAL).
Who is sponsoring clinical trial NCT04131062?
This trial is sponsored by Geisinger Clinic, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04131062 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Lynch Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04131062's enrollment target sits among peer trials
703 8th of 21 higher than 14 of 21 other Lynch Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Lynch Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Identifying and Caring for Individuals With Inherited Cancer Syndrome
RECRUITING · NA
-
A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule
RECRUITING · NA
-
Menstrual Cup for Early Endometrial Cancer Detection in Lynch Syndrome
RECRUITING · NA
-
Feasibility Study: IGNITE-TX (Identifying Individuals for Genetic Testing & Treatment) Intervention
ACTIVE NOT RECRUITING · NA
-
Weight Management and Health Behavior Intervention in Lowering Cancer Risk for BRCA Positive and Lynch Syndrome Families
ACTIVE NOT RECRUITING · NA
-
Energy Balance Interventions in Increasing Physical Activity in Breast Cancer Gene Positive Patients, Lynch Syndrome-Positive Patients, CLL Survivors or High-Risk Family Members
ACTIVE NOT RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05796687 · 704 participants · NA
Evaluation of My Future Self, an New Teen Pregnancy Prevention Group Intervention for Youth in Non-traditional Settings
- NCT06350734 · 704 participants
Quality of Life After Treatment for Bladder Cancer: The Bladder Cancer Survivorship Study
- NCT06027996 · 702 participants · NA
Melodi Matrix™ in Breast Reconstruction
- NCT06480383 · 705 participants · Phase 2
Study of ITI-1284 as an Adjunctive Treatment in Patients With Generalized Anxiety Disorder
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI